Cornerstone Robotics (CSR), a leading global innovator in surgical robotics based in Hong Kong, China, has announced that its Sentire® Endoscopic Surgical System has officially received European Union CE mark certification under the Medical Device Regulation (MDR), covering minimally invasive surgical procedures in General Surgery, Gynecology, Thoracic and Urology. This milestone formally grants the Sentire® Surgical System access to the European markets.
The Sentire® Surgical System is a high-end surgical robotic platform that combines clinical workflows with integrated engineering, software, and imaging technologies.
The company established an early presence in the UK. Since 2025, CSR has partnered with Portsmouth Hospitals University NHS Trust (PHU) to undertake a fully compliant clinical investigation of the Sentire® Surgical System, steadily accumulating real-world clinical data to support evidence-based research, training protocol development, and clinical adoption.
To date, the Sentire® Surgical System has completed numerous complex procedures in the UK, spanning core specialties including urology, gynecology, and upper and lower gastrointestinal surgery. The investigation achieved the patient outcomes and the clinicians were very satisfied with the system's performance.
In November 2025, the startup successfully completed an oversubscribed financing round of approximately $200 million, underscoring strong confidence from leading international investors in its long-term growth potential and global commercial capabilities.
